A Dutch biotech cre­at­ing nasal sprays to pro­tect against the flu and coro­n­avirus has raised an ad­di­tion­al $70 ...

Lon­za’s Synaf­fix has se­cured two sep­a­rate li­cens­ing deals with Boehringer In­gel­heim and Japan­ese drug­mak­er ...

Novo Holdings co-leads €32M Series A for Coave Therapeutics, which is developing gene therapies with its ALIGATER technology.

French biotech MaaT Pharma says its acute graft-versus-host disease treatment exceeded expectations in a single-arm Phase 3 ...

Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver ...

There's a shopping bonanza for new obesity medicines going on among a marquee cohort of biopharma investors who are ...

Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown ...

Tenvie Therapeutics launches with $200M, acquires Denali drug candidates, led by Tony Estrada with NLRP3 and SARM1 inhibitors ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

Jasper Therapeutics continued building out the data for a drug designed to treat irritable skin conditions, though the latest ...

National Resilience is laying off 120 staffers from its gene therapy facility in North Carolina, only a month after the San ...

Astellas has ended work on a cell therapy that it was exploring for CD20-positive B cell lymphomas, the Japan-based pharma ...